Cargando…
Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma
Medication-related osteonecrosis of the jaw is a known side-effect of antiresorptive therapy in patients with malignant diseases. Nevertheless, the exact pathogenesis is still unknown and published prevalences show a significant range. The aim of the presented paper was to assess the prevalence of o...
Autores principales: | Rugani, Petra, Walter, Christian, Kirnbauer, Barbara, Acham, Stephan, Begus-Nahrman, Yvonne, Jakse, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806952/ https://www.ncbi.nlm.nih.gov/pubmed/29563474 http://dx.doi.org/10.3390/dj4040032 |
Ejemplares similares
-
The effectiveness of decompression as initial treatment for jaw cysts: A 10-year retrospective study
por: Marin, Saša, et al.
Publicado: (2019) -
Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients
por: Walter, Christian, et al.
Publicado: (2010) -
Extraoral Root-End Resection May Promote Pulpal Revascularization in Autotransplanted Mature Teeth—A Retrospective Study
por: Rugani, Petra, et al.
Publicado: (2022) -
Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma
por: Krstevska, Svetlana, et al.
Publicado: (2015) -
Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients
por: Melea, Pelagia I., et al.
Publicado: (2014)